Patent 11759457 was granted and assigned to Azurity Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.
Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.